YL

Yanke Liang

CT C4 Therapeutics: 5 patents #2 of 23Top 9%
DI Dana-Farber Cancer Institute: 3 patents #9 of 212Top 5%
The General Hospital: 2 patents #23 of 336Top 7%
TI The Broad Institute: 1 patents #64 of 203Top 35%
📍 Belmont, MA: #3 of 213 inventorsTop 2%
🗺 Massachusetts: #247 of 14,432 inventorsTop 2%
Overall (2024): #12,611 of 561,600Top 3%
8
Patents 2024

Issued Patents 2024

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12180225 N/O-linked degrons and degronimers for protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Minsheng He, Martin Duplessis +1 more 2024-12-31
12168663 Inhibitors of cyclin-dependent kinase 7 (CDK7) Nathanael S. Gray, Tinghu Zhang, Nicholas Paul Kwiatkowski 2024-12-17
12121521 Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis Marc Wein, Henry M. Kronenberg, Thomas Sundberg, Ramnik Xavier, Nathanael S. Gray +2 more 2024-10-22
12076405 Heterocyclic degronimers for target protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Mark Fitzgerald, Minsheng He +1 more 2024-09-03
12048748 Spirocyclic degronimers for target protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Kiel Lazarski, Ryan E. Michael 2024-07-30
12048747 Substituted piperidine Degronimers for Target Protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Chi-Li Chen, Martin Duplessis +2 more 2024-07-30
11992531 C3-carbon linked glutarimide degronimers for target protein degradation Andrew J. Phillips, Christopher G. Nasveschuk, James A. Henderson, Minsheng He, Kiel Lazarski +2 more 2024-05-28
11878019 Uses of pyrimidopyrimidinones as SIK inhibitors David E. Fisher, Nisma Mujahid, Ryo Murakami, Nathanael S. Gray, Hwan Geun Choi 2024-01-23